Editorial: Advances in the pharmacotherapy of chronic pelvic pain conditions

Editorial: Advances in the pharmacotherapy of chronic pelvic pain conditions

Saved in:

Bibliographic Details
Main Authors:	Elena Lucarini, Javier Aguilera-Lizarraga, Miguel Ángel Tejada
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Pharmacology
Subjects:	chronic pelvic pain inflammatory bowel disease irritable bowel syndrome vulvodynia endometriosis prostatitis
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1546059/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

When the pain does not go away – a case report on a comprehensive biopsychosocial physiotherapy approach for refractory vulvodynia treatment
by: Weronika Solomon, et al.
Published: (2024-03-01)

Prevalence of anhedonia in women with deep endometriosis
by: Aida Mallorquí, et al.
Published: (2025-01-01)

The Impact of Chronic Pelvic Pain and Bowel Morbidity on Quality of Life in Cervical Cancer Patients Treated With Radio (Chemo) Therapy. A Systematic Literature Review
by: Natuhwera G, et al.
Published: (2025-02-01)

Pain science education concepts for pelvic pain: an e-Delphi of expert clinicians
by: Amelia K. Mardon, et al.
Published: (2025-02-01)

Inflammatory Bowel Diseases and Irritable Bowel Syndrome: Overlap of Two Nosological Forms or Two Variants of the Same Disease?
by: A. A. Sheptulin, et al.
Published: (2019-12-01)

The effect of dienogest and gonadotropin-releasing hormone agonist on pelvic pain after laparoscopic surgery for endometriosis: An RCT
by: Fatemeh Davari Tanha, et al.
Published: (2025-02-01)

Issues of diagnostics and treatment of abdominal pain at irritable bowel syndrome at outpatient stage of the healthcare
by: Yu. A. Kucheryavy, et al.
Published: (2015-12-01)

Pregnancy - Related Pelvic Girdle Pain
by: Esma Sarıkaya, et al.
Published: (2014-08-01)

PPARγ activation attenuates neonatal CRD-induced visceral pain sensitization and anxiety in male rats by alleviating oxidative stress
by: Minjie Li, et al.
Published: (2025-01-01)

Diagnosis and Treatment of Irritable Bowel Syndrome: Clinical Recommendations of the Russian Gastroenterological Association and Association of Coloproctologists of Russia
by: V. T. Ivashkin, et al.
Published: (2022-01-01)

Fermented-milk bacteria: role in intestinal peristalsis regulation
by: Yu. O. Shulpekova
Published: (2010-06-01)

Prednisolone pharmacokinetics in dogs with protein‐losing enteropathy
by: Sara A. Jablonski, et al.
Published: (2025-01-01)

Chronic pelvic pain treatment understanding what matters: a social media survey
by: Selina Johnson, et al.
Published: (2025-01-01)

Discussion of the problem of functional constipation and irritable bowel syndrome in the reports of the International Congress on Neurogastroenterology and Motility (Bologna, 2012)
by: A. A. Sheptulin, et al.
Published: (2013-03-01)

Current Prospects of Herbal STW 5 Agent in Treatment of Functional Gastrointestinal Diseases
by: A. A. Sheptulin
Published: (2022-01-01)

Effect of biofeedback – therapy on clinical semiology, quality of life and sensorimotor function of anorectal area at irritable bowel syndrome with refractory constipation
by: O. V. Krapivnaya
Published: (2014-07-01)

Combined alverine citrate and simeticonein preparation in the treatment of irritable bowel syndrome
by: Ye. A. Poluektova, et al.
Published: (2012-07-01)

Acute enteritis with pelvic SBRT: Influence of bowel delineation methods
by: Akshay Dinesan, et al.
Published: (2025-05-01)

Diagnostic Algorithm for Joint Pain in Patients with Inflammatory Bowel Disorders
by: A. I. Dolgushina, et al.
Published: (2022-01-01)

Discussion of irritable bowel syndrome issue and functional constipations in reports of the 21st United European Gastroenterological Week (Berlin, 2013)
by: A. A. Sheptulin, et al.
Published: (2014-09-01)

The Efficacy of Lubiprostone in Patients of Constipation: An Updated Systematic Review and Meta‐Analysis
by: Umar Akram, et al.
Published: (2025-01-01)

Postinfectious Irritable Bowel Syndrome: Polemic and Open Issues
by: A. A. Sheptulin, et al.
Published: (2022-03-01)

Acetylcholine in irritable bowel syndrome pathogenesis and the role of cholineblockers
by: Yu. O. Shulpekova
Published: (2011-02-01)

The treatment of irritable bowel syndrome from the modern views on the disease pathogenesis
by: Ye. A. Poluektova, et al.
Published: (2013-03-01)

The Impact of Hangeshashinto on Symptoms and Gut Microbiota in Diarrhea-type Irritable Bowel Syndrome: A Retrospective Analysis
by: Naohisa Yoshida, et al.
Published: (2025-01-01)

Diagnosis of Functional Gastrointestinal Disorders and Choice of Treatment Regimen in Constipation Patients
by: I. V. Maev, et al.
Published: (2021-10-01)

Diagnostic Possibilities of Determining the Level of Faecal Calprotectin in Clinical Practice
by: A. A. Sheptulin, et al.
Published: (2023-05-01)

Irritable Bowel Syndrome: What Are the Reasons for Dissatisfaction with the Treatment of Patients and Doctors? (Based on the Experience of Medical Institutions of the Northwestern Federal District of Russia)
by: A. Yu. Baranovsky, et al.
Published: (2024-01-01)

Colorectal Cancer in Patient with Functional Gastrointestinal Symptoms
by: Z. A. Mamieva, et al.
Published: (2022-01-01)

Functional Disorders of the Gastrointestinal Tract During the Pandemic of a New Coronavirus Infection
by: A. A. Sheptulin, et al.
Published: (2022-09-01)

Features of nervous system in children with irritable bowel syndrome
by: O. K. Botvin’yev, et al.
Published: (2011-12-01)

Gastroesophageal reflux disease and the functional diseases of gastro-intestinal tract: are there any interrelations?
by: A. A. Sheptulin, et al.
Published: (2010-08-01)

Combination of functional dyspepsia syndrome and irritable bowel syndrome
by: V. T. Ivashkin, et al.
Published: (2011-06-01)

Irritable Bowel Syndrome Diagnosis: Should There Be Alertness to Cancer?
by: A. A. Sheptulin, et al.
Published: (2019-05-01)

Irritable Bowel Syndrome in Terms of Changes in the Microbiota
by: Vladimir T. Ivashkin, et al.
Published: (2019-03-01)

Pathogenetic Substantiation of the Therapeutic Impact on Microbiota in Irritable Bowel Syndrome
by: Yu. O. Shulpekova, et al.
Published: (2019-09-01)

Experience in the Treatment of Irritable Bowel Syndrome Developed after a New Coronavirus Infection (COVID-19)
by: R. G. Myazin
Published: (2022-05-01)

Serum salusin levels in diarrhea- and constipation-predominant irritable bowel syndrome
by: Elif Tugba Tuncel, et al.
Published: (2025-01-01)

Propionic Acid-Producing Bacteria as Provocateurs of Anxiety and Depression? [Letter]
by: Prescott SL, et al.
Published: (2025-02-01)

COVID-19 Pandemic and Irritable Bowel Syndrome — is there a Relationship?
by: V. A. Akhmedov
Published: (2022-08-01)